Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

Fig. 3

Metabolic profile during the follow-up. a Number of subjects with any laboratory abnormality at baseline, week 24 and week 48. b Variation of metabolic indicators from baseline, mean values; c Variation in triglycerides (different scale). AST = Aspartate Aminotransferase; ALT = Alanine Aminotransferase; HDL-C = High-Density Lipoprotein - Cholesterol; LDL-C = Low-Density Lipoprotein - Cholesterol; MDRD = Modified Diet for Renal Disease; TC = Total Cholesterol

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us